United States· US:80491-8012_68b78342-ced1-436d-b591-bb14e1a9a2f7
TRYVIO
A aprocitentan product containing aprocitentan, registered in United States by Idorsia Pharmaceuticals Ltd. The same ATC class is registered in 10 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Aprocitentan is registered in 10 of 19 countries.
Countries holding a registration under ATC C02KN01 (aprocitentan), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 7 of them publish a price we can compare per daily dose
Aprocitentan · ATC C02KN01
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- APROCITENTAN
- Manufacturer
- Idorsia Pharmaceuticals Ltd
- Country
- United States (US)
- ATC code
- C02KN01
- ATC class
- Aprocitentan
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- August 23, 2026
Packs & prices · 4
- ndc1180491801231 BOTTLE in 1 CARTON (80491-8012-3) / 30 TABLET, FILM COATED in 1 BOTTLE
- ndc1180491801281 BLISTER PACK in 1 CARTON (80491-8012-8) / 10 TABLET, FILM COATED in 1 BLISTER PACK (80491-8012-7)
- ndc1180491-8012-3
- ndc1180491-8012-8
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Aprocitentan in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaJERAYGOIdorsia Pharmaceuticals Deutschland GmbH, Lörrach
- SwitzerlandJeraygo 12.5 mg, FilmtablettenIdorsia Pharmaceuticals Ltd
- IrelandJERAYGO 12.5 mg film-coated tabletsIdorsia Pharmaceuticals Deutschland GmbH
- IcelandJERAYGOIdorsia Pharmaceuticals Deutschland GmbH
- NetherlandsJERAYGO 12,5 mg filmomhulde tablettenIdorsia Pharmaceuticals Deutschland GmbH
- PolandJeraygoIdorsia Pharmaceuticals Deutschland GmbH
- SwedenJERAYGO 12,5 mg Filmdragerad tablettIdorsia Pharmaceuticals Deutschland GmbH
- BelgiumJeraygo 12.5 mgIdorsia Pharmaceuticals Deutschland
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Jeraygo
- Liechtenstein · Jeraygo
- Norway · Jeraygo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ea087f26-4570-48b5-8b79-84f505c35346 GET /v1/drugs/ea087f26-4570-48b5-8b79-84f505c35346?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "12.5",
"substance": "APROCITENTAN",
"productndc": "80491-8012",
"dosage_form": "TABLET, FILM COATED",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "NDA217686",
"marketing_category": "NDA"
}See everything about aprocitentan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.